SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cadus Corp – ‘S-8 POS’ on 12/23/97 – EX-5

As of:  Tuesday, 12/23/97   ·   Effective:  12/23/97   ·   Accession #:  889812-97-2729   ·   File #:  333-21871

Previous ‘S-8 POS’:  ‘S-8 POS’ on 3/10/97   ·   Next:  ‘S-8 POS’ on 4/5/16   ·   Latest:  ‘S-8 POS’ on 4/5/16

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

12/23/97  Cadus Corp                        S-8 POS    12/23/97    4:12K                                    Global Fin’l Press/NY/FA

Post-Effective Amendment to an S-8   —   Form S-8
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8 POS     Post-Effective Amendment No. 2                         5     21K 
 2: EX-4        Amendment No. 2 to Cadus Pharmaceutical                1      5K 
                          Corporation 1996 Incentive Plan                        
 3: EX-5        Opinion of Morrison Cohen Singer & Weinstein, LLP,     2±     8K 
                          as to the Validity of the Securities                   
                          Being Registered                                       
 4: EX-23.1     Consent of Kpmg Peat Marwick LLP                       1      5K 


EX-5   —   Opinion of Morrison Cohen Singer & Weinstein, LLP, as to the Validity of the Securities Being Registered

EX-5TOCTopPreviousNextBottomJust 1st
 

EXHIBIT 5 OPINION OF COUNSEL [Letterhead of Morrison Cohen Singer & Weinstein, LLP] (212) 735-8600 December 17, 1997 Cadus Pharmaceutical Corporation 777 Old Saw Mill River Road Tarrytown, New York 10591 Re: Cadus Pharmaceutical Corporation Post-Effective Amendment No. 2 to Registration Statement on Form S-8 Gentlemen: We have acted as counsel to Cadus Pharmaceutical Corporation, a Delaware corporation (the "Company"), in connection with the preparation of Post-Effective Amendment No. 2 to the Registration Statement on Form S-8 ("Amendment No. 2") being filed by the Company with the Securities and Exchange Commission under the Securities Act of 1933, as amended, covering an aggregate of an additional 1,000,000 shares (the "Shares") of common stock of the Company, $.01 par value per share (the "Common Stock"), issuable upon the exercise of stock options and stock appreciation rights which may be granted under the Company's 1996 Incentive Plan (the "Plan"). In so acting, we have examined copies of such records of the Company and such other certificates and documents as we have deemed relevant and necessary for the opinion hereinafter set forth. In such examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals and the conformity to authentic originals of all documents submitted to us as certified or reproduced copies. We have also assumed the legal capacities of all persons executing such documents and the truth and correctness of any representations or warranties contained therein. As to various questions of fact material to such opinion, we have relied upon certificates of officers of the Company. Based upon and subject to the foregoing, we are of the opinion that the Shares issuable upon exercise of the stock options and stock appreciation rights which may be granted under the Plan, when paid for and issued in accordance with the terms of such stock options and stock appreciation rights, will be validly issued and fully paid and nonassessable. We hereby consent to your filing copies of this opinion as an exhibit to Amendment No. 2. Very truly yours, /s/ Morrison Cohen Singer & Weinstein, LLP MORRISON COHEN SINGER & WEINSTEIN, LLP

Dates Referenced Herein

This ‘S-8 POS’ Filing    Date    Other Filings
Filed on / Effective on:12/23/97None on these Dates
12/17/97
 List all Filings 
Top
Filing Submission 0000889812-97-002729   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 6:13:15.1pm ET